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The object of this work stems from our previous stud-
ies on the mechanisms responsible of ribose-1-phos-
phate- and 5-phosphoribosyl-1-pyrophosphate-mediated
nucleobase salvage and 5-fluorouracil activation in rat
brain (Mascia, L., Cappiello M., Cherri, S., and Ipata,
P. L. (2000) Biochim. Biophys. Acta 1474, 70–74; Mascia,
L., Cotrufo, T., Cappiello, M., and Ipata, P. L. (1999) Bio-
chim. Biophys. Acta 1472, 93–98). Here we show that
when ATP at “physiological concentration” is added to
dialyzed extracts of rat brain in the presence of natural
nucleobases or 5-fluorouracil, adenine-, hypoxanthine-,
guanine-, uracil-, and 5-fluorouracil-ribonucleotides are
synthesized. The molecular mechanism of this peculiar
nucleotide synthesis relies on the capacity of rat brain
to salvage purine and pyrimidine bases by deriving ri-
bose-1-phosphate and 5-phosphoribosyl-1-pyrophos-
phate from ATP even in the absence of added pentose or
pentose phosphates. The levels of the two sugar phos-
phates formed are compatible with those of synthesized
nucleotides. We propose that the ATP-mediated 5-phos-
phoribosyl-1-pyrophosphate synthesis occurs through
the action of purine nucleoside phosphorylase, phos-
phopentomutase, and 5-phosphoribosyl-1-pyrophos-
phate synthetase. Furthering our previous observations
on the effect of ATP in the 5-phosphoribosyl-1-pyrophos-
phate-mediated 5-fluorouracil activation in rat liver
(Mascia, L., and Ipata, P. L. (2001) Biochem. Pharma-
col. 62, 213–218), we now show that the ratio [5-phos-
phoribosyl-1-pyrophosphate]/[ATP] plays a major role
in modulating adenine salvage in rat brain. On the
basis of our in vitro results, we suggest that massive
ATP degradation, as it occurs in brain during ische-
mia, might lead to an increase of the intracellular
5-phosphoribosyl-1-pyrophosphate and ribose-1-phos-
phate pools, to be utilized for nucleotide resynthesis
during reperfusion.
It is well established that inosine and other ribonucleosides
are transported into mammalian cells (1, 2) where they modu-
late the processes of nucleobase salvage and 5-fluorouracil
(5-FUra)1 activation (3–8). The molecular mechanism relies on
the enhancement of the cytosolic ribose-1-phosphate (Rib1-P)
level, stemming from nucleoside phosphorolysis and the subse-
quent synthesis of 5-phosphoribosyl-1-pyrophosphate (PRPP).
Alternatively, Rib1-P may be converted into phosphorylated
glycolytic intermediates via the pentose pathway (9). In previ-
ous papers, we have followed the time course of purine and
pyrimidine ribonucleotides and 5-FUra-ribonucleotides biosyn-
thesis in extracts of rat brain incubated with ATP and a nucleo-
base in the presence of Rib1-P or a Rib1-P-generating system
such as inosine and Pi (10–13). During these studies we be-
came aware that, after prolonged incubation, a small, but def-
inite amount of nucleobases could be salvaged into their respec-
tive ribonucleotides even in the absence of Rib1-P or inosine
(14). A related observation was the marked effect exerted by
ATP in modulating the PRPP-mediated 5-FUra activation to
cytotoxic 5-FUra-nucleotides (12) as catalyzed by rat liver oro-
tate phosphoribosyltransferase (the PRPP pathway) (14, 15).
Taken together, these observations prompted us to undertake a
study on the capacity of rat brain to salvage purine and pyrim-
idine bases by deriving Rib1-P and PRPP from ATP and to
ascertain whether the salvage of purine bases might be modu-
lated by ATP. In this paper, we show that: (i) massive ATP
breakdown per se, as it probably occurs in rat brain during
ischemia (16), may provide at least part of the Rib 1-P and of
the PRPP needed to salvage uracil and purine bases, respec-
tively; (ii) the [PRPP]/[ATP] ratio modulates the process of
adenine salvage in rat brain extracts. We recall that in rat
brain, which does not possess the de novo nucleotide synthesis,
purine and pyrimidine salvage is particularly active (3, 13, 17).
EXPERIMENTAL PROCEDURES
Materials—[8-14C]Adenine (55 mCi/mmol), [8-14C]hypoxanthine (54
mCi/mmol), [8-14C]guanine (53.3 mCi/mmol), [2-14C]cytosine (51 mCi/
mmol), [2-14C]uracil (54 mCi/mmol), [2-14C]5-FUra (55 mCi/mmol),
adenosine deaminase, hypoxanthine-guanine phosphoribosyltrans-
ferase (HGPRT), PRPP, dithiothreitol, nucleobases, nucleosides, and
nucleotides were from Sigma. Adenosine deaminase and HGPRT were
diluted with 5 mM Tris-HCl buffer before use to contain 0.63 units/ml
and 10 units/ml, respectively. Bacillus cereus adenosine phosphorylase
(0.14 units/ml) was prepared as described previously (18). Hi Safe II
scintillation liquid was purchased from Wallac. Polyethyleneimine
(PEI)-cellulose precoated thin-layer plastic sheets (0.1-mm thick) were
purchased from Merck and prewashed once with 10% NaCl and three
times with deionized water before use. All other chemicals were of
reagent grade. Three-month-old male Sprague-Dawley rats were killed
according to the “Guiding Principles in the Care and Use of Animals”
(DHWEW, publication no. NIH 86-23). The brain was removed and kept
frozen at 80 °C until needed. Storage time did not exceed 2 months.
Preparation of Rat Brain Extracts—Rat brain was cut in small
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pieces, washed with cold saline, and gently homogenized with a hand-
driven Potter homogenizer in 3 volumes of 100 mM Tris-HCl buffer, pH
7.4, with 20 mM KCl and 1 mM dithiothreitol. The homogenate was
centrifuged at 4 °C at 40,000 g for 1 h. The supernatant fluid obtained
was dialyzed overnight at 4 °C in dialysis bags against 10 mM Tris-HCl
buffer, pH 7.4, supplemented with 1 mM dithiothreitol and is referred to
as crude extract. The levels of the purine and pyrimidine salvage
enzymes present in crude extract are reported in a previous paper (13).
Incubation Procedures—Crude extracts, containing 50–150 g of
protein, were incubated in a total reaction volume of 70 l containing 5
mM Tris-HCl buffer, pH 7.4, 1 mM [8-14C]adenine (8,000 dpm/nmol),
[8-14C]hypoxanthine (8,000 dpm/nmol), [8-14C]guanine (25,000 dpm/
nmol), [2-14C]cytosine (10,000 dpm/nmol), [2-14C]uracil (12,000 dpm/
nmol), or [2-14C]5-FUra (12,000 dpm/nmol), 3.6 mM ATP, and 8.3 mM
MgCl2. Modifications of the standard incubation mixture are indicated
in the figure legends. The reaction was started by the addition of crude
extract. At different time intervals, the reaction was stopped by rapidly
drying portions of 10 l of the incubation mixture on PEI-cellulose
precoated thin-layer plastic sheets, and a chromatogram was developed
in n-butanol/glacial acetic acid/H2O (4:2:1, v/v) to separate adenosine
and adenine-nucleotides, and cytidine and cytosine-nucleotides, or with
n-propanol/NH3/trichloroacetic acid (100%)/H2O (75:0.7:5:20, v/v) to
separate inosine and hypoxanthine-nucleotides, guanosine and gua-
nine-nucleotides, uridine and uracil-nucleotides, and 5-fluorouridine
and 5-FUra-nucleotides. In all separations, appropriate standards were
used and detected as ultraviolet absorbing areas, which were excised
and counted for radioactivity with 8 ml of scintillation liquid.
Determination of ATP-derived Rib1-P and PRPP—Crude extracts,
containing 1100 g of protein, were incubated in a total reaction volume
of 500 l in the presence of 3.6 mM ATP, 8.3 MgCl2, 5 mM Tris-HCl
FIG. 1. Time courses of ATP-mediated adenine salvage (A) and
PRPP formation (B) catalyzed by rat brain crude extracts. A, the
incubation mixture contained, in a final volume of 70 l, 100–150 g of
protein, 70 nmol of [8-14C]adenine, 252 nmol of ATP, and 581 nmol of
MgCl2, in 5 mM Tris-HCl buffer, pH 7.4., adenosine; Œ, AMP; , ADP
 ATP. B, [8-14C]Adenine was omitted in the reaction mixture, and
PRPP was determined as described under “Experimental Procedures.”
, PRPP. A bidimensional chromatographic analysis of the reaction
mixture incubated for 60 min gave an ATP/ADP ratio of about 9:1.
FIG. 2. Time courses of ATP-mediated hypoxanthine salvage
(A) and Rib1-P formation (B) catalyzed by rat brain crude ex-
tracts. A, the incubation mixture was as in Fig. 1 with the exception of
[8-14C]hypoxanthine (70 nmol), which substituted [8-14C]adenine. ,
inosine; Œ, IMP; , IDP  ITP. B, [8-14C]Hypoxanthine was omitted,
and Rib1-P was determined as described under “Experimental Proce-
dures.” , Rib1-P.
FIG. 3. Time courses of ATP-mediated uracil salvage (A) and
5-FUra activation (B) catalyzed by rat brain crude extracts. A,
the incubation mixture was as described in Fig. 1 with the exception of
[2-14C]uracil (70 nmol), which substituted [8-14C]adenine. , uridine;
Œ, UMP; , UDP  UTP. B, [2-14C]Uracil was substituted with 70
nmol of [2-14C]5-FUra. , 5-fluorouridine; Œ, 5-fluorouridine 5-mono-
phosphate; , 5-fluorouridine 5-diphosphate  5-fluorouridine
5-triphosphate.
FIG. 4. Time course of ATP-mediated guanine salvage cata-
lyzed by rat brain crude extracts. A, the incubation mixture was as
described in the legend for Fig. 1 with the exception of [8-14C]guanine
(70 nmol), which substituted [8-14C]adenine. Œ, GMP; , GDP  GTP;
, xanthine; , xanthosine; ‚, xanthosine 5-monophosphate.
FIG. 5. Effect of nucleobases on ATP-mediated purine and py-
rimidine ribonucleotides (A) and ribonucleosides (B) synthesis
in rat brain crude extracts. The standard incubation mixture con-
tained, in a final volume of 60 l, 100–150 g of protein, 12 nmol each
of [8-14C]adenine, [8-14C]hypoxanthine, [8-14C]guanine, [2-14C]cytosine,
or [2-14C]uracil, 216 nmol of ATP, 498 nmol of MgCl2 in 5 mM Tris-HCl
buffer, pH 7.4, in the presence of a mixture of 12 nmol each of the other
four cold nucleobases. A, , total adenine nucleotides; Œ, total uracil
nucleotides;, total hypoxanthine nucleotides; f, total guanine nucle-
otides. B, E, adenosine; ‚, uridine; , inosine; , xanthosine.
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buffer, pH 7.4. The incubation was carried out at 37 °C. At different
time intervals, 70-l portions were withdrawn, heated for 90 s at
100 °C, and centrifuged. The supernatant fluid was used to determine
Rib 1-P and PRPP.
Rib1-P was determined according to Ipata and Camici (18). Briefly,
25 l of the above supernatant fluid was added to 20 l of 10 mM
[8-14C]adenine (8,000 dpm/nmol) in 5 mM Tris-HCl buffer, pH 7.4, 10 l
of diluted commercial adenosine deaminase, and 5 l of the adenosine
phosphorylase preparation. The reaction mixtures were incubated at
37 °C for 2 h. Then, 10-l portions were applied to a PEI-cellulose
precoated thin-layer plastic sheet and developed with deionized water.
The marker compounds were detected with a UV lamp. The zones
corresponding to inosine were excised and counted for radioactivity
with 8 ml of scintillation liquid.
PRPP was determined according to King et al. (19), with minor
modifications. Briefly, 25 l of the above supernatant fluid was added to
10 l of 10 mM [8-14C]hypoxanthine (8,000 dpm/nmol) in 5 mM Tris-HCl
buffer, pH 7.4, 2 l of the diluted HGPRT, 1 l of 100 mM dithiothreitol,
2 l of 2 mM MgCl2, and 10 l of Tris-HCl, pH 7.4. The reaction mixtures
were incubated at 37 °C for 10 min. Then 10 l was applied to a
PEI-cellulose precoated thin-layer plastic sheet and developed with 1.4
M LiCl. The marker compounds were detected with a UV lamp. The
zones corresponding to IMP were excised and counted for radioactivity
with 8 ml of scintillation liquid.
Protein Concentration—Protein concentration was determined by the
Coomassie Blue binding assay using bovine serum albumin as standard
(20).
RESULTS AND DISCUSSION
It is a widely accepted tenet in neurobiology that under
normal conditions intracellular ATP levels are rigorously pro-
tected. However, in such events as ischemia or anoxia, massive
ATP breakdown occurs. Many reports have demonstrated a
substantial recovery of rat brain adenine nucleotides levels
following ischemic episodes (16, 21–27). Moreover, a consider-
able increase in intracellular nucleosides and nucleobases, im-
portant precursors of nucleotide resynthesis following reperfu-
sion, has been reported (16, 28). This paper deals with two
different, although related, aspects of ATP metabolism in rat
brain. First, we have shown that PRPP, in addition to Rib1-P,
may be synthesized during massive ATP breakdown and uti-
lized to salvage purine bases (Figs. 1-5). Second, we have
shown that the [PRPP]/[ATP] ratio is an important factor in
modulating the purine salvage process in rat brain (Figs. 6 and
7). Essentially, the rational of our experimental approach was
the following. Because in rat brain adenine, hypoxanthine and
guanine salvage are PRPP-dependent processes (3), we rea-
soned that any ATP-mediated purine ribonucleotide biosynthe-
sis would necessarily imply that PRPP was synthesized during
ATP breakdown. Likewise, because uracil salvage and 5-FUra
activation are Rib 1-P-dependent processes in rat brain (12,
FIG. 6. Effect of varying the concen-
tration of ATP on adenine salvage at
fixed PRPP concentration. The incu-
bation mixture contained, in a final vol-
ume of 60 l, 100–150 g of protein, 60
nmol of [8-14C]adenine, 6 nmol of PRPP,
276 nmol of MgCl2, and 120 nmol (), 60
nmol (Œ), 30 nmol (), 6 nmol (f), 3 nmol
(*), or 0 nmol () of ATP and 276 nmol of
MgCl2, in 5 mM Tris-HCl buffer, pH 7.4.
The inset shows the maximal amount of
total adenine nucleotides (TAN) synthe-
sized as a function of ATP concentration.
FIG. 7. Effect of varying the concen-
tration of PRPP on adenine salvage
at fixed ATP concentration. A, the in-
cubation mixture contained, in a final vol-
ume of 30 l, 70–80 g of protein, 30
nmol of [8-14C]adenine, 108 nmol of ATP,
249 nmol of MgCl2, and 90 nmol (*),30
nmol (Œ), 15 nmol (), 7.5 nmol (f, or 1.5
nmol of PRPP () in 5 mM Tris-HCl
buffer, pH 7.4. Panel B shows the maxi-
mal amount of total adenine nucleotides
(TAN) synthesized as a function of PRPP
concentration.
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13), any ATP-mediated uridine- and 5-FUra-ribonucleotide bio-
synthesis would necessarily imply that Rib1-P was formed
during ATP breakdown. The results will be discussed with the
aid of the scheme presented in Fig. 8.
ATP-mediated Adenine Salvage and PRPP Formation—Fig.
1A shows the time course of radioactive adenosine and adenine-
nucleotide formation as catalyzed by crude extract of rat brain
incubated in the presence of [14C]adenine and ATP. A striking
observation here was the absence of any [14C]adenosine forma-
tion. It is evident that any AMP synthesized by the PRPP-
mediated phosphoribosylation of adenine was further phospho-
rylated rather then being hydrolyzed to adenosine. Fig. 1B
gives direct evidence of free PRPP formation in incubation
carried out in the absence of adenine. The most obvious path-
way for PRPP synthesis during ATP breakdown is that com-
posed of purine nucleoside phosphorylase, phosphopento-
mutase and PRPP synthetase (reactions 6, 7, and 8 in Fig. 8).
Because the latter enzyme has an absolute requirement of Pi
for its activity (29), it is conceivable that some endogenous Pi,
as well as the release of Pi from added ATP, might have been
responsible for the PRPP synthetase activation. Interestingly,
the amount of PRPP synthesized after 80 min of incubation
(Fig. 1B) was in good correlation with that of total adenine
nucleotides present in the reaction mixture after the same
incubation time.
ATP-mediated Hypoxanthine Salvage and Rib1-P Forma-
tion—Fig. 2A shows the time course of [14C]hypoxanthine com-
pounds formed when crude extract of rat brain was incubated
in the presence of [14C]hypoxanthine and ATP. Both inosine
and IMP were synthesized. The latter, however, was not fur-
ther phosphorylated. Most likely Rib1-P, formed during ATP
breakdown, was utilized to ribosylate hypoxanthine, whereas
PRPP was utilized to phosphoribosylate hypoxanthine through
the action of purine nucleoside phosphorylase and HGPRT
activities present in rat brain, respectively. Because no inosine
kinase activity is present in mammalian tissues (30), phospho-
rylation of inosine can be excluded a priori. We cannot exclude
the possibility that a small portion of IMP might have arisen by
the action of the phosphotransferase activity of cytosolic 5-
nucleotidase (31) as well as that some inosine might have
arisen from IMP dephosphorylation. We noticed, however, that
the amount of free Rib1-P formed in the absence of added
nucleobase (Fig. 2B) was in good correlation with that of total
inosine synthesized (Fig. 2A). A chromatographic analysis of
the UV absorbing products of ATP breakdown clearly showed
that IMP was formed before adenosine. Thus, IMP was already
present in the reaction mixture after 10 min of incubation,
whereas adenosine and hypoxanthine appeared after 20 and 60
min, respectively. ATP and ADP completely disappeared only
after 2 h of incubation.
ATP-mediated Uracil Salvage and 5-FUra Activation—
When crude extract of rat brain was incubated in the presence
of either [14C]uracil (Fig. 3A) or [14C]5-FUra (Fig. 3B) and ATP,
uridine and 5-fluorouridine were synthesized as intermediates
of uracil- and 5-FUra-ribonucleotides synthesis, respectively
(reactions 12 and 13 in Fig. 8) in accordance with the existence
of high uridine phosphorylase and uridine kinase activities in
rat brain (13) and with our previous results showing that
5-FUra activation occurs through the Rib1-P-mediated ribosy-
lation of the pyrimidine analog followed by multiple phospho-
rylation steps (“the Rib1-P pathway”) (12).
ATP-mediated Guanine Salvage—Utilization of [14C]gua-
nine during ATP breakdown appears to be rather complex. Fig.
4 shows that a series of radioactive compounds was formed
including guanine-nucleotides, xanthine, xanthosine, and
XMP. Changes in the specific radioactivities of metabolites to
ascertain their order of formation have not been analyzed. Such
experiments would be helpful in the future. The appearance of
large amounts of xanthine and xanthosine in the course of
reaction is indicative of strong guanine deaminase and purine
nucleoside phosphorylase activities and of recycling of Rib1-P
in the nucleoside interconversion (32). The activity of xanthine
oxidase in rat brain is very low (33). Because xanthine is not
used as substrate by mammalian HGPRT (34), and we are not
aware of the existence of any nucleoside kinase acting on xan-
thosine, the small amount of XMP formed might be ascribed to
the phosphotransferase activity of rat brain cytosolic 5-nucle-
otidase (35).
ATP-mediated Cytosine Salvage—Strikingly, cytosine was
not utilized at all during ATP breakdown (results not shown),
showing that the base is not deaminated to uracil and confirm-
ing the absence of cytidine phosphorylase and cytosine phos-
phoribosyltransferase activities in rat brain (13).
As shown in Fig. 5, the patterns of the ATP-mediated salvage
of each radioactive nucleobase is not significantly altered by
the presence of all other cold nucleobases.
Modulation of Adenine Salvage by the [PRPP]/[ATP] Ratio—
The intracellular ATP level in mammalian tissues is in the mM
range (e.g. 3.3 mM in rat brain (36)), whereas that of PRPP in
mammalian tissues is in the M range (37). Most likely, the
[PRPP]/[ATP] ratio must be maintained at low values to avoid
excessive de novo or “salvage” purine nucleotide synthesis. And
in fact PRPP synthetase superactivity, a rare abnormality in
man, leads to purine overproduction, gout, and urolithiasis
(38). The results presented in Fig. 6 and 7 suggest that the
[PRPP]/[ATP] ratio might modulate the process of adenine
salvage. The maximal amount of adenine salvaged at a fixed
FIG. 8. Pathways for ATP-mediated Rib1-P and PRPP forma-
tion in rat brain extract. The upper part of the scheme is taken from
Torrecilla et al. (39) (slightly modified). The enzymes participating in
these pathways are: 1, adenylate kinase; 2, adenylate deaminase; 3,
5-nucleotidase; 4, adenosine kinase; 5, adenosine deaminase; 6, purine
nucleoside phosphorylase; 7, phosphopentomutase; 8, PRPP-synthe-
tase; 9, adenine-phosphoribosyltransferase; 10, HGPRT; 11, guanine
deaminase; 12, uridine phosphorylase; and 13, uridine kinase. Ade,
adenine; Ado, adenosine; Hyp, hypoxanthine; Ino, inosine; Urd, uridine;
Guo, guanosine; Gn, guanine; Xn, xanthine; Xao, xanthosine.
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initial PRPP concentration was a function of ATP levels (Fig.
6). Moreover, the rate of salvaged adenine nucleotides degra-
dation observed after prolonged incubation increased sharply
by decreasing the initial ATP concentration. These observa-
tions further suggest that the ATP level might be an important
factor in modulating the PRPP-mediated process of purine base
salvage. As expected, at fixed “physiological” rat brain ATP
concentration (36), the maximal amount of adenine salvaged
was a function of initial PRPP levels (Fig. 7).
An artifactual presence of ecto-5-nucleotidase in our brain
extract cannot be excluded a priori. In our view, the presence of
this enzyme does not invalidate the results presented here,
which can be extrapolated to an in vivo situation because, as
pointed out by Torrecilla et al. (39), in the presence of an ATP
concentration as low as 10 M, this enzyme would not have
functional importance related to the metabolism of AMP
(40, 41).
In conclusion, our results suggest that rat brain has the
capacity to salvage the main natural purine and pyrimidine
bases, except cytosine, and to activate 5-FUra by deriving
Rib1-P and PRPP from ATP. In our opinion, this process rep-
resents the real salvage of nucleobases and might explain the
capacity of the brain to achieve reperfusion-recovery of certain
nucleotide pools lost during hypoxia. In addition, our results
suggest that the ratio [PRPP]/[ATP] plays a major role in
modulating the salvage process of purine nucleotides.
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